Product image of Glucagen (Glucagon) supplied by GNH India

Glucagen

Active Ingredient:
Glucagon
Origin:
EU

Glucagen (Glucagon)

Glucagen is a prescription injectable solution that contains the peptide hormone glucagon as its active ingredient. It is supplied in an unspecified strength and is administered by intramuscular, intravenous, or subcutaneous injection. Marketed in the European Union, Glucagen belongs to the antihypoglycemic therapeutic class and is used to rapidly raise blood glucose levels in emergency situations. It is intended for use under medical supervision and is prescription‑only.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucagen is indicated for specific acute medical conditions where rapid elevation of blood glucose is required.

  • Treatment of severe hypoglycemia in patients with diabetes when oral glucose is ineffective or unavailable.
  • Emergency management of hypoglycemia in unconscious or unable-to‑swallow individuals.
  • Reversal of beta‑blocker or calcium‑channel blocker overdose when conventional therapies are insufficient.
  • Use as a diagnostic aid in certain endocrine testing protocols.

Side Effects

The safety profile of Glucagen reflects the pharmacologic actions of glucagon and the route of administration.

Common

  • Nausea or vomiting
  • Flushing or warmth at the injection site
  • Transient headache
  • Mild abdominal discomfort

Serious

  • Severe allergic reaction (anaphylaxis) with rash, itching, swelling, or difficulty breathing
  • Rapid heart rate (tachycardia) or irregular heartbeat
  • Persistent high blood pressure
  • Hypersensitivity leading to angioedema

Precautions & Warnings

Healthcare providers should consider several precautions before prescribing or administering Glucagen to ensure patient safety.

  • Verify the patient’s diagnosis of hypoglycemia and assess for possible glucagon contraindications.
  • Use caution in patients with pheochromocytoma or adrenal medullary tumors due to potential hypertensive response.
  • Monitor cardiovascular status in individuals with known heart disease, as glucagon can increase heart rate and contractility.
  • Adjust dosing in pediatric patients according to weight‑based guidelines and clinical response.
  • Avoid use in patients with known hypersensitivity to glucagon or any formulation components.
  • Ensure proper storage away from light and at recommended temperature to maintain potency.

Avoid Interactions

Glucagen may interact with other medications or substances, influencing its effectiveness or safety.

Avoid

  • Concurrent use of beta‑blockers that may mask typical glucagon‑induced tachycardia.
  • Combination with insulin analogs administered shortly before glucagon, which can exacerbate glucose fluctuations.

Use with caution

  • Anticholinergic agents, as they may affect gastrointestinal motility and absorption of glucose.
  • Calcium‑channel blockers, because combined cardiovascular effects may require monitoring.
  • MAO inhibitors, which could alter autonomic responses during hypoglycemia treatment.

Frequently Asked Questions

Glucagen is a prescription injectable solution that contains glucagon, a peptide hormone that stimulates hepatic glycogenolysis and gluconeogenesis, rapidly increasing blood glucose levels.

Glucagen is used when a patient with diabetes experiences severe hypoglycemia that cannot be corrected with oral glucose or when the patient is unconscious or unable to swallow.

Glucagen can be given by intramuscular, intravenous, or subcutaneous injection, depending on the clinical situation and the provider’s assessment.

Common adverse effects include nausea, vomiting, flushing or warmth at the injection site, transient headache, and mild abdominal discomfort.

Serious reactions such as anaphylaxis, severe rash, swelling, difficulty breathing, rapid or irregular heartbeat, persistent hypertension, or angioedema should be treated as medical emergencies.

Glucagen should not be used in patients with known hypersensitivity to glucagon or any component of the formulation.

Store Glucagen in a cool, dry place away from direct light, and follow the manufacturer’s temperature guidelines to preserve stability.

Yes, Glucagen can be administered to children, but dosing should be weight‑based and performed under medical supervision.

Avoid concurrent use of beta‑blockers that may mask glucagon‑induced tachycardia and insulin analogs given shortly before glucagon, as they can cause unpredictable glucose swings.

Glucagon can counteract the negative cardiac effects of beta‑blocker overdose by increasing intracellular cyclic AMP, improving heart rate and contractility.

No, Glucagen is classified as a prescription‑only medication in the European Union.

After injection, monitor blood glucose levels, cardiovascular status, and observe for any adverse reactions, especially in patients with heart disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucagon

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT